Breast cancer followed by corpus cancer: Is there a higher risk for aggressive histologic subtypes?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breast cancer followed by corpus cancer: Is there a higher risk for aggressive histologic subtypes?

Published:2006-09 Issue:3 Volume:102 Page:508-512
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Chan John K.,Manuel Michael R.,Cheung Michael K.,Osann Kathryn,Husain Amreen,Teng Nelson N.,Rao Anjali,Carlson Robert W.,Whittemore Alice S.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference17 articles.

1. Association between uterine serous carcinoma and breast cancer;Gehrig;Gynecol. Oncol.,2004

2. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma;Geisler;Gynecol. Oncol.,2001

3. Tamoxifen therapy for breast cancer and endometrial cancer risk;Bernstein;J. Natl. Cancer Inst.,1999

4. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14;Fisher;J. Natl. Cancer Inst.,1994

5. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers;Fornander;Lancet,1989

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of breast cancer-related gene prognostic signature in endometrial cancer;2024-05-10

2. Breast Cancer Patients Are at Increased Risk of Developing Uterine Serous Cancer: Implications for Counseling – A SEER Analysis;Oncology Research and Treatment;2022

3. Concomitant diagnosis of endometrial and breast cancer - does the sequence matters?;Gynecologic Oncology Reports;2021-11

4. Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors?;Journal of Oncology Pharmacy Practice;2021-05-13

5. Breast Cancer Patients at Increased Risk of Developing Type II Endometrial Cancer: Relative and Absolute Risk Estimation and Implications for Counseling;Cureus;2021-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3